30.10.2013 Aufrufe

Leitlinie zur Behandlung der aktinischen Keratosen (PDF)

Leitlinie zur Behandlung der aktinischen Keratosen (PDF)

Leitlinie zur Behandlung der aktinischen Keratosen (PDF)

MEHR ANZEIGEN
WENIGER ANZEIGEN

Erfolgreiche ePaper selbst erstellen

Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.

6. Literaturverzeichnis <strong>Behandlung</strong> <strong>der</strong> <strong>aktinischen</strong> <strong>Keratosen</strong> <strong>Behandlung</strong> <strong>der</strong> <strong>aktinischen</strong> <strong>Keratosen</strong><br />

6. Literaturverzeichnis<br />

Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of<br />

5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 1996;<br />

192: 246–51.<br />

Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M,<br />

Ulrich J, Proebstle T, Meffert H, Mul<strong>der</strong> M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L. Photodynamic<br />

therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis:<br />

a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258–262.<br />

Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod<br />

5 % cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehiclecontrolled,<br />

clinical trial with histology. J Am Acad Dermatol. 2004; 51(4): 547–55.<br />

Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, Reich K, Pabst G, Voss D,<br />

Foguet M, Gahlmann R, Lübbert H, Reinhold U. Photodynamic therapy with BF-200 ALA for the treatment<br />

of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.<br />

Br J Dermatol. 2010, 163: 386–394.<br />

Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare<br />

two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and<br />

scalp. Acta Derm Venereol 2005; 85: 424–8.<br />

Thai KE, Fer gin P, Free man M et al. A prospective study of the use of cryosurgery for the treatment of actinic<br />

keratoses. Int J Dermatol 2004; 43: 687–692.<br />

Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;<br />

329:1147–51.<br />

Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin<br />

cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring<br />

and interventions. Br J Dermatol. 2007; 156 Suppl 3: 1–7.<br />

Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis<br />

Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic<br />

keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol.<br />

2006; 155: 1262–9.<br />

Tse Y, Ostad A, Lee HS et al. A clinical and histologic evaluation of two medium-depth peels. Glycolic acid<br />

vs. Jessner’s trichloroacetic acid. Dermatol Surg 1996; 22: 781–6.<br />

Ulrich C, Christophers E, Sterry W, Meyer T, Stockfleth E. Skin diseases in organ transplant patients. Hautarzt<br />

2002; 53: 524–533.<br />

Ulrich C, Bichel J,Euvrard S, Guidi B, Proby CM, van de Kerkhof PCM, Amerio P, Rønnevig J, Slade HB, Stockfleth<br />

E. Topical immunomodulation un<strong>der</strong> systemic immunosuppression: results of a multicentre, randomized,<br />

placebo-controlled safety and efficacy study of imiquimod 5 % cream for the treatment of actinic keratoses<br />

in kidney, heart, and liver transplant patients. Br J Dermatol. 2007a, 157 (Suppl. 2), 25–31.<br />

Ulrich C, Hackethal M, Ulrich M, Howorka A, Forschner T, Sterry W, Stockfleth E. Treatment of multiple<br />

actinic keratoses with topical diclofenac 3 % gel in organ transplant recipients: a series of six cases. Br J<br />

Dermatol. 2007b; 156 Suppl 3: 40–2.<br />

Ulrich C, Degen A, Patel MJ, Stockfleth E. Sunscreens in organ transplant patients. Nephrol Dial Transplant.<br />

2008 Jun; 23: 1805–8.<br />

Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin cancer in organ transplant recipients -Where do we stand<br />

today? Am J Transplantation, 2008 Nov; 8(11): 2192–8.<br />

Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth<br />

E. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24<br />

months, prospective, case-control study.Br J Dermatol. 2009 Nov; 161 Suppl 3: 78–84.<br />

Ulrich C, Johannsen A, Röwert-Huber J, Ulrich M, Sterry W, Stockfleth E. Results of a randomized, placebocontrolled<br />

safety and efficacy study of topical diclofenac 3 % gel in organ transplant patients with multiple<br />

actinic keratoses. Eur J Dermatol. 2010 JulAug; 20(4): 482–8.<br />

Ulrich M, Maltusch A, Röwert-Huber J, González S, Sterry W, Stockfleth E, Astner S. Actinic keratoses: noninvasive<br />

diagnosis for field cancerisation. Br J Dermatol. 2007; 156 Suppl 3: 13–7.<br />

Warino L, Tusa M, Camacho F, Teuschler H, Fleischer AB Jr, Feldman SR. Frequency and cost of actinic keratosis<br />

treatment. Dermatol Surg. 2006; 32: 1045–9.<br />

Watson AB. Preventative effect of etretinate therapy on multiple actinic keratoses. Cancer Detect Prev<br />

1986; 9:161–5.<br />

Winton GB, Salasche SJ. Dermabrasion of the scalp as a treatment for actinic damage. J Am Acad Dermatol<br />

1986; 14: 661–8.<br />

Witheiler DD, Lawrence N, Cox SE et al. Long-term efficacy and safety of Jessner’s solution and 35 %<br />

trichloroacetic acid vs. 5 % fluorouracil in the treatment of widespread facial actinic keratoses. Dermatol<br />

Surg 1997; 23: 191–6.<br />

Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratoses by Er:YAG laser. J<br />

Cutan Laser Ther 2001; 3: 63–6.<br />

Wolf JR, Taylor JR, Tschen E. Topical 3 % diclofenac in 2.5 % hyaluronan gel in the treatment of actinic<br />

keratoses. Int J Dermatol 2001; 40: 709–13.<br />

Wulf HC, Pavel S, Sten<strong>der</strong> I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new<br />

skin lesions in renal transplant recipients. Acta Derm Venereol. 2006; 86: 25–8.<br />

Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Nonsteroidal antiinflammatory drugs induce<br />

apoptosis in association with activation of peroxisome proliferatoractivated receptor gamma in rheumatoid<br />

synovial cells. J Pharmacol Exp Ther. 2002 Jul; 302(1): 18–25.<br />

Yantsos VA, Conrad N, Zabawski E, Cockerell CJ. Incipient intraepi<strong>der</strong>mal cutaneous squamous cell carcinoma:<br />

a proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg 1999;<br />

18(1): 3–14.<br />

Yu TC, Rahman Z, Ross BS. Actinic keratoses--surgical and physical therapeutic modalities. Cutis 2003; 71:<br />

381–4.<br />

Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented<br />

skin tumors: a review of vascular structures seen with <strong>der</strong>moscopy: part II. Nonmelanocytic skin tumors. J<br />

Am Acad Dermatol. 2010; 63(3): 377–86.<br />

Zouboulis ChC. Principles of cutaneous cryosurgery: An update. Dermatology 1999; 198: 111–117.<br />

Zouboulis CC, Röhrs H. Cryosurgical treatment of actinic keratoses and evidence-based review Hautarzt.<br />

2005 Apr; 56: 353–8.<br />

46 47

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!